Dr. Patricia S. Rotter, MD

Dr. Rotter practices at Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.

Dr. Rotter's NPI, 1407826050, was assigned on January 25, 2006. Dr. Rotter graduated from Vanderbilt University School of Medicine in 2002. Dr. Rotter holds Oregon license MD26707.

Dr. Rotter's primary practice is Providence Portland Medical Center, at 4805 NE Glisan Street, Portland, OR 97213 in Multnomah County. The practice phone is (503) 215-1111.

Dr. Rotter's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services. Dr. Rotter is also affiliated with Kaiser Permanente Sunnyside Medical Center. The medical group on file is Kaiser Permanente Northwest. Dmand AI also links Dr. Rotter to 1 more hospital, 5 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rotter practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Rotter's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Rotter is licensed in Oregon.

CMS data shows 760 Medicare services from Dr. Rotter across 6 procedure codes in 2024, for 76 Medicare patients. Medicare paid $58,369 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Rotter in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rotter's median patient age at 69, with 58% women.

In 2024, Dr. Rotter wrote 124 Medicare Part D claims for 59 patients. 90% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $328 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Rotter for performance year 2024, reported as part of a group. Dr. Rotter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 254 procedures of removal of tissue by Dr. Rotter, more than 93% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 11 general payments to Dr. Rotter from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $223.

Dr. Rotter graduated from Vanderbilt University School of Medicine in 2002.